SNC
GILD icon

Stifel Nicolaus & Co’s Gilead Sciences GILD Stock Holding History

Stifel Nicolaus & Co’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$7.26M Buy
115,547
+68,179
+144% +$4.07M 0.12% 178
2013
Q2 		$2.43M Buy
+47,368
New +$2.47M 0.04% 381

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stifel Nicolaus & Co's GILD Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Gilead Sciences (GILD) stake by 144% in Q3 2013, buying an estimated $4.07M and bringing the position to 115,547 shares worth $7.26M. The position accounts for 0.12% of the portfolio, ranked #178.

Stifel Nicolaus & Co first reported a position in GILD in Q2 2013 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Stifel Nicolaus & Co held 115,547 shares of Gilead Sciences worth $7.26M as of Q3 2013.
  • Stifel Nicolaus & Co bought 68,179 Gilead Sciences shares in Q3 2013, an estimated $4.07M.
  • Gilead Sciences made up 0.12% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #178 holding.
  • Stifel Nicolaus & Co first reported a position in Gilead Sciences in Q2 2013 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.